We are live on
!
Find out more
MIM
MetLife Investment Management Portfolio holdings
AUM
$19.6B
1-Year Est. Return
32.64%
This Fund
S&P 500
This Quarter
Est. Return
+4.92%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$8.47B
AUM Growth
-$26.4M
(-0.31%)
Cap. Flow
-$317M
Cap. Flow
% of AUM
-3.74%
Top 10 Holdings %
Top 10 Hldgs %
16.75%
Holding
2,295
New
113
Increased
604
Reduced
562
Closed
131
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$33.8M |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$16.4M |
| 3 |
AT&T
T
|
+$9.63M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$7.05M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$6.76M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$44.9M |
| 2 |
Booking.com
BKNG
|
+$30.5M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$22.2M |
| 4 |
MON
Monsanto Co
MON
|
+$15.5M |
| 5 |
Apple
AAPL
|
+$14.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.18% |
| 2 | Financials | 16.58% |
| 3 | Healthcare | 12.69% |
| 4 | Industrials | 10.83% |
| 5 | Consumer Discretionary | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABMD
301
DELISTED
Abiomed Inc
ABMD
| $5.09M | 0.06% |
12,439
-13,812
| -53% | -$5M |
|
|
CDK
302
DELISTED
CDK Global, Inc.
CDK
| $5.06M | 0.06% |
77,752
-1,181
| -1% | -$76.4K |
|
303
L3Harris
LHX
$53.3B
| $5.05M | 0.06% |
34,951
-780
| -2% | -$121K |
|
|
NBL
304
DELISTED
Noble Energy, Inc.
NBL
| $5.03M | 0.06% |
142,608
-5,511
| -4% | -$187K |
|
305
Ingredion
INGR
$6.6B
| $5.03M | 0.06% |
45,404
+325
| +0.7% | +$38.2K |
|
306
Idacorp
IDA
$8.11B
| $5.03M | 0.06% |
54,473
+224
| +0.4% | +$20.1K |
|
307
Vulcan Materials
VMC
$37.3B
| $5.02M | 0.06% |
38,912
-957
| -2% | -$118K |
|
308
Tyler Technologies
TYL
$13.2B
| $4.97M | 0.06% |
22,379
+382
| +2% | +$85.9K |
|
309
Textron
TXT
$15.2B
| $4.97M | 0.06% |
75,371
-3,406
| -4% | -$220K |
|
310
Chemours
CC
$2.23B
| $4.96M | 0.06% |
111,817
-3,735
| -3% | -$186K |
|
311
TransDigm Group
TDG
$68.7B
| $4.95M | 0.06% |
14,354
-255
| -2% | -$83.8K |
|
|
WGL
312
DELISTED
Wgl Holdings
WGL
| $4.93M | 0.06% |
55,580
+870
| +2% | +$75.7K |
|
313
Verisk Analytics
VRSK
$23.6B
| $4.92M | 0.06% |
45,729
-952
| -2% | -$101K |
|
314
Ametek
AME
$58.8B
| $4.92M | 0.06% |
68,171
-1,446
| -2% | -$107K |
|
315
RPM International
RPM
$14.9B
| $4.9M | 0.06% |
84,049
+634
| +0.8% | +$31.8K |
|
316
NOV
NOV
$7.49B
| $4.88M | 0.06% |
112,458
-1,911
| -2% | -$77.4K |
|
|
XLNX
317
DELISTED
Xilinx Inc
XLNX
| $4.87M | 0.06% |
74,596
-2,087
| -3% | -$142K |
|
318
NorthWestern Energy
NWE
$4.35B
| $4.86M | 0.06% |
84,804
+269
| +0.3% | +$14.6K |
|
319
Cognex
CGNX
$10.6B
| $4.85M | 0.06% |
108,697
+392
| +0.4% | +$18.6K |
|
320
Factset
FDS
$10.1B
| $4.84M | 0.06% |
24,433
+80
| +0.3% | +$16K |
|
321
United Airlines
UAL
$41B
| $4.84M | 0.06% |
69,377
-3,449
| -5% | -$240K |
|
322
Emcor
EME
$36B
| $4.84M | 0.06% |
63,491
+311
| +0.5% | +$24.1K |
|
323
Zebra Technologies
ZBRA
$18.1B
| $4.81M | 0.06% |
33,561
+330
| +1% | +$48.6K |
|
324
Huntington Bancshares
HBAN
$35.9B
| $4.8M | 0.06% |
325,283
-6,453
| -2% | -$97K |
|
325
WEX
WEX
$6.44B
| $4.8M | 0.06% |
25,182
+207
| +0.8% | +$36.1K |
|
Similar funds
SPIA
BG
PCM
CS
HHII
A
LF
MetLife Investment Management's Q2 2018 Portfolio in Review
As of Q2 2018, MetLife Investment Management held 2,295 positions worth $8.47B, down 0.31% from $8.49B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
MetLife Investment Management withdrew a net $317M in Q2 2018, closing 131 positions and reducing 562 holdings. Its most notable exit was DuPont de Nemours, an estimated $44.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
Against the trend, MetLife Investment Management opened a new position in Bank of New York Mellon worth $16M.
- MetLife Investment Management's largest Q2 2018 buy was Bank of New York Mellon: 297,519 shares worth $16M.
- MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $33.8M increase.
- MetLife Investment Management's biggest Q2 2018 reduction was Apple, cutting an estimated $14.5M.
- MetLife Investment Management fully exited DuPont de Nemours in Q2 2018, selling an estimated $44.9M.
- MetLife Investment Management's ten largest holdings make up 17% of its $8.47B portfolio in Q2 2018.
- MetLife Investment Management opened 113 new positions and closed 131 in Q2 2018.
- MetLife Investment Management's portfolio value fell 0.31% quarter-over-quarter to $8.47B.
Based on MetLife Investment Management's 13F filing for Q2 2018, filed 15 Aug 2018.